Teva and Takeda Agree to Commercialize Rasagiline for Parkinson’s Disease Treatment in Japan

Teva and Takeda Agree to Commercialize Rasagiline for Parkinson’s Disease Treatment in Japan

[Business Wire] – Teva Pharmaceutical Industries Ltd. and Takeda Pharmaceutical Company Limited have signed an agreement allowing Takeda to commercialize Teva’s innovative treat more

View todays social media effects on TEVA

View the latest stocks trending across Twitter. Click to view dashboard

See who Teva is hiring next, click here to view

Share this post